Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Asset Utilization Ratio (2016 - 2026)

Pharma-Bio Serv's Asset Utilization Ratio history spans 14 years, with the latest figure at 0.65 for Q1 2026.

  • For Q1 2026, Asset Utilization Ratio rose 9.38% year-over-year to 0.65; the TTM value through Jan 2026 reached 0.65, up 9.38%, while the annual FY2025 figure was 0.6, 14.41% up from the prior year.
  • Asset Utilization Ratio reached 0.65 in Q1 2026 per PBSV's latest filing, down from 0.66 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.01 in Q3 2022 to a low of 0.58 in Q4 2024.
  • Average Asset Utilization Ratio over 5 years is 0.78, with a median of 0.77 recorded in 2024.
  • Peak YoY movement for Asset Utilization Ratio: skyrocketed 45.34% in 2022, then tumbled 30.95% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.95 in 2022, then decreased by 10.78% to 0.84 in 2023, then crashed by 30.95% to 0.58 in 2024, then rose by 13.32% to 0.66 in 2025, then dropped by 1.83% to 0.65 in 2026.
  • Per Business Quant, the three most recent readings for PBSV's Asset Utilization Ratio are 0.65 (Q1 2026), 0.66 (Q4 2025), and 0.67 (Q3 2025).